PSA 117 ng/ml – Prostate cancer? / Dr. Cherepanov
Tel.: +7-918-361-39-71 WhatsApp
Urologist - Andrologist Denis Anatolyevich Cherepanov
https://drcherepanov.ru/
A man's genetic makeup ensures the development of not only normal but also pathological tissue. In particular, sooner or later, a benign tumor will form in the prostate gland, which can lead to malignant growth, i.e., prostate cancer.
Statistically, this process begins at age 45. However, it can develop earlier and later. It is slow and gradual. A tumor that is significant for a man takes several years to develop, and it becomes malignant after 10-20 years, but there are exceptions to this rule. Men complain of difficulty and frequent urination, needing to get up at night to go to the bathroom, experiencing pain in the lower abdomen, perineum, and scrotum, and experiencing difficulties in sexual activity. The primary diagnostic tools for prostate adenoma are a PSA blood test and transrectal prostate ultrasound (TRUS).
When a tumor or prostate adenoma begins to form, a specific protein, prostate-specific antigen (PSA), is released into the bloodstream. As the tumor develops and grows, PSA levels increase. Normal levels of up to 1.4 ng/ml are considered—at this level, treatment is necessary. PSA levels above 4 ng/ml significantly increase the risk of cancer. Extremely high levels may indicate prostate cancer—a diagnosis confirmed by histological examination of prostate biopsy specimens, i.e., a prostate biopsy.
We discuss men's and women's health issues: reproductive medicine, family planning, infertility, male infertility, female infertility, infertility screening, andrology, urology, reproductive medicine, general health, proper nutrition, exercise, and much more. Krasnodar, Moscow, St. Petersburg, Volgograd, Voronezh, Yekaterinburg, Izhevsk, Kazan, Krasnoyarsk, Nizhny Novgorod, Novosibirsk, Perm, Rostov-on-Don, Samara, Sochi, Tyumen, Ufa, Chelyabinsk, Yaroslavl.